Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Moolec ScienceMLEC +0.07%42 Days Sales Outstanding is 121.70 as of Dec. 2025, which is 49% above its 10-year median of 81.93. GuruFocus rates MLEC with a GF Score™ of 42/100 and a GF Value™ of $84.84 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 839 Biotechnology companies, Moolec Science ranks better than 97.5% on this metric.
Moolec Science (NAS:MLEC) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Moolec Science Days Sales Outstanding Related Terms
Moolec Science Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Moolec Science's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLEC vs BRTX, ERNA, LABT: Days Sales Outstanding Comparison
For the Biotechnology subindustry, Moolec Science's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Moolec Science Days Sales Outstanding vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Moolec Science's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Moolec Science's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 121.70 mean?
Moolec Science (MLEC) has a Days Sales Outstanding of 121.70 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Moolec Science and its competitors. This is 49% above median its historical median of 81.93. Over the past decade, Moolec Science's Days Sales Outstanding has ranged from 0.31 to 117.66. According to the industry distribution chart, Moolec Science ranks #21 out of 839 companies in the Biotechnology industry, placing it in the top 2.5%.
Is Moolec Science's Days Sales Outstanding too high?
Moolec Science's current Days Sales Outstanding of 121.70 is 49% above median its 10-year median of 81.93. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 117.66. The Biotechnology industry median Days Sales Outstanding is 68.64. Moolec Science's value of 121.70 is 77.3% above this industry median. Based on the distribution chart, Moolec Science ranks #21 out of 839 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Moolec Science has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Moolec Science's Days Sales Outstanding compare to BRTX and ERNA?
According to the Biotechnology industry distribution chart, Moolec Science ranks #21 out of 839 companies for Days Sales Outstanding. This places Moolec Science in the top 3% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 68.64. Moolec Science's value of 121.70 is 77.3% above this benchmark. Historically, Moolec Science's own Days Sales Outstanding has ranged from 0.31 to 117.66 over the past decade. While the company's 10-year median is 81.93 vs. the industry median of 68.64, Moolec Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Biotechnology company?
The median Days Sales Outstanding among Biotechnology companies is 68.64, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Moolec Science's current Days Sales Outstanding of 121.70 is 77.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Moolec Science and its competitors. For the Biotechnology industry, the median Days Sales Outstanding is 68.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Moolec Science's current Days Sales Outstanding is 121.70, which is 49% above median its own 10-year median of 81.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moolec Science stock overvalued right now?
Based on GuruFocus' analysis, Moolec Science (MLEC) is currently considered Possible Value Trap. The stock's GF Value™ is $84.84, compared to a current price of $6.80 — trading 92% below its estimated fair value. The current Days Sales Outstanding is 121.70, which is 49% above median its 10-year median of 81.93 and 77.3% above the Biotechnology industry median of 68.64. Moolec Science's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Moolec Science (MLEC), the current Days Sales Outstanding is 121.70 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Moolec Science (MLEC) Overvalued in 2026?
Based on GuruFocus' analysis, Moolec Science stock appears to be undervalued.
The current stock price of $6.80 is trading 92% below its estimated GF Value™ of $84.84.
GuruFocus considers Moolec Science to be Possible Value Trap.
Key valuation signals for MLEC:
Days Sales Outstanding: 121.70 (49% above median its 10-year median of 81.93)
GF Value™: $84.84 vs. price of $6.80 (92% below fair value)
Industry Position: 77.3% above the Biotechnology median (#21 of 839)
No single metric tells the full story. See the MLEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
42GF Score
Get the complete analysis for MLEC
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLEC has been successfully added to your 
